Mergers and acquisitions

Pfizer confirms generic medicines merger with Mylan

https://pharmaphorum.com/news/pfizer-confirms-generic-medicines-merger-with-mylan/

BMS will shed Otezla to push Celgene takeover through

https://pharmaphorum.com/news/bms-will-shed-otezla-to-push-celgene-takeover-through/

Sanofi steals in to buy Ablynx for €3.9 billion

https://pharmaphorum.com/news/sanofi-steals-buy-ablynx-e3-9-billion/

Novo Nordisk and Celgene lead January pharma M&A

https://pharmaphorum.com/news/novo-nordisk-celgene-lead-january-pharma-ma/

Biotech and big pharma heading for a M&A filled 2018

https://pharmaphorum.com/news/biotech-big-pharma-heading-ma-filled-2018/

Takeda to buy Ariad for $5.2bn

https://pharmaphorum.com/news/takeda-buy-ariad-5-2bn/

Johnson & Johnson back in ‘exclusive’ talks to buy Actelion

https://pharmaphorum.com/news/johnson-johnson-back-exclusive-talks-buy-actelion/

BIND accepts Pfizer bid following bankruptcy

https://pharmaphorum.com/news/bind-accepts-pfizer-stalking-horse-bid-following-motion-sell-assets/

Celgene’s new CEO weighs in to drug pricing debate

https://pharmaphorum.com/views-and-analysis/celgene-s-new-ceo-weighs-in-to-drug-pricing-debate/

1 2

Close in 10 seconds

Pharmaphorum.com

Search